Review of health economics modelling in rheumatoid arthritis-Reference-Cited by-同舟云学术

Review of health economics modelling in rheumatoid arthritis

Published:2004-09 Issue:S1 Volume:22 Page:55-69
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:Pharmacoeconomic

Author:

Emery Paul

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.2165/00019053-200422001-00006.pdf

Reference59 articles.

1. Tugwell P. Pharmacoeconomics of drug therapy for rheumatoid arthritis. Rheumatology 2000; 39 Suppl. 1: 43–7

2. Ruchlin HS, Elkin EB, Paget SA. Assessing cost-effectiveness analyses in rheumatoid arthritis and osteoarthritis. Arthritis Care Res 1997; 10 (6): 413–21

3. Ruof J, Hülsemann JL, Stucki G. Evaluation of costs in rheumatic diseases: a literature review. Curr Opin Rheumatol 1999; 11 (2): 104–9

4. Lipsky PE, Kavanaugh A. The impact of pharmaco-economic considerations on the utilization of novel anti-rheumatic therapies. Rheumatology 1999; 38 Suppl. 2: 41–4

5. Borg G, Allander E, Goobar JE. Disease-modifying anti-rheumatic drug therapy. An expensive therapy despite inexpensive drugs. Scand J Rheumatol 1990; 19 (2): 115–21

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis;Nature Reviews Rheumatology;2024-09-09

2. Mechanism‐driven strategies for prevention of rheumatoid arthritis;Rheumatology & Autoimmunity;2022-06-15

3. Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis;Value in Health;2015-03

4. Including Adverse Drug Events in Economic Evaluations of Anti-Tumour Necrosis Factor-α Drugs for Adult Rheumatoid Arthritis: A Systematic Review of Economic Decision Analytic Models;PharmacoEconomics;2013-12-15

5. Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia;Rheumatology International;2013-08-02